Literature DB >> 21267995

IL-22 in antifungal immunity.

Teresa Zelante1, Rossana Iannitti, Antonella De Luca, Luigina Romani.   

Abstract

Deciphering cellular and molecular mechanisms that maintain host immune homeostasis with fungi and the breakdown of this homeostatic tolerance during fungal infections disease is a challenge in medical mycology. In fact, the virulence of fungi may be determined by the interaction between fungi and the host immune status and its classification as a commensal microorganism or a pathogen may shift depending on the balance. In addition to the central role of the IL-12/IFN-γ-dependent Th1 responses in cell-mediated immune protection against fungi, Th17 cells provide protection and inflammation at mucosal surfaces, and Tregs fine-tune immune responses to prevent damage to the host. Recent evidence indicates that IL-22-producing cells, employing primitive antifungal effector mechanisms, contribute to antifungal resistance at mucosal surfaces under conditions of defective adaptive immunity. The fact that IL-22 production is driven by commensals points to the need of an integrated, systems biology approach to improve our understanding of the inherent and intimate mechanisms underlying multilevel host-fungus interactions.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21267995     DOI: 10.1002/eji.201041246

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

Review 1.  The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism.

Authors:  Luigina Romani; Teresa Zelante; Melissa Palmieri; Valerio Napolioni; Matteo Picciolini; Andrea Velardi; Franco Aversa; Paolo Puccetti
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

2.  Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis.

Authors:  Felix E Y Aggor; Timothy J Break; Giraldina Trevejo-Nuñez; Natasha Whibley; Bianca M Coleman; Rachel D Bailey; Daniel H Kaplan; Julian R Naglik; Wei Shan; Amol C Shetty; Carrie McCracken; Scott K Durum; Partha S Biswas; Vincent M Bruno; Jay K Kolls; Michail S Lionakis; Sarah L Gaffen
Journal:  Sci Immunol       Date:  2020-06-05

Review 3.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Authors:  Vanessa Espinosa; Amariliz Rivera
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

Review 4.  Microbial-induced Th17: superhero or supervillain?

Authors:  Mandy J McGeachy; Stephen J McSorley
Journal:  J Immunol       Date:  2012-10-01       Impact factor: 5.422

Review 5.  IL-17 signaling in host defense against Candida albicans.

Authors:  Sarah L Gaffen; Nydiaris Hernández-Santos; Alanna C Peterson
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

6.  Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells.

Authors:  Patricia A Valdez; Paul J Vithayathil; Brian M Janelsins; Arthur L Shaffer; Peter R Williamson; Sandip K Datta
Journal:  Immunity       Date:  2012-03-29       Impact factor: 31.745

Review 7.  Adaptive immunity to fungi.

Authors:  Marcel Wüthrich; George S Deepe; Bruce Klein
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 8.  Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy.

Authors:  Anna R Huppler; Shrinivas Bishu; Sarah L Gaffen
Journal:  Arthritis Res Ther       Date:  2012-07-23       Impact factor: 5.156

9.  Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections.

Authors:  N Hernández-Santos; A R Huppler; A C Peterson; S A Khader; K C McKenna; S L Gaffen
Journal:  Mucosal Immunol       Date:  2012-12-19       Impact factor: 7.313

10.  Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.

Authors:  Adrien Katalin Sarkadi; Szilvia Taskó; Gabriella Csorba; Beáta Tóth; Melinda Erdős; László Maródi
Journal:  J Clin Immunol       Date:  2014-02-04       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.